Skip to main content
. Author manuscript; available in PMC: 2014 Oct 1.
Published in final edited form as: Histopathology. 2013 Aug 8;63(4):499–508. doi: 10.1111/his.12207

Figure 4. Association of MYC immunohistochemical staining scores with clinical outcomes in MCL.

Figure 4

(A) Kaplan–Meier plot of progression free survival (PFS) for MCL cases dichotomized at the median MYC IHC score of 10%. (B) Kaplan-Meier plot of overall survival (OS). Number of subjects at risk is listed above the X-axis. NR = not reached.